SIHUAN PHARM: Plans to spin off shares of XuanZhu Biotechnology and list on the main board of the Hong Kong Stock Exchange

USHK News
2024.11.12 14:22

Jin10 Data reported on November 12 that SIHUAN PHARM announced that the board of directors has decided to spin off the shares of XuanZhu Bio and list them on the main board of the Hong Kong Stock Exchange, and has obtained approval from the Hong Kong Stock Exchange for the proposed spin-off of XuanZhu Bio. At the same time, Hainan SIHUAN has entered into an equity transfer agreement with Sunshine Life to further acquire approximately 3.6177% of the shares of XuanZhu Bio for a total price of about 308 million yuan

Source: USHK News The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.